CMF-00040 | LRP2 | up-regulates | NFKB1 | activates | R-299 | 25 | 5 | Drugs (6) |
CMF-00085 | LRP2 | up-regulates | FOXJ3 | activates | R-1168 | 23 | 4 | Drugs (7) |
CMF-00102 | LRP2 | up-regulates | ZFX | activates | R-798 | 23 | 8 | Drugs (1) |
CMF-00366 | COL6A3 | up-regulates | PLAG1 | activates | R-2510 | 5 | 4 | Drugs (5) |
CMF-00919 | USP35 | down-regulates | CEBPA | activates | R-2596 | 21 | 3 | Drugs (6) |
CMF-01167 | SKAP2 | up-regulates | NFKB1 | activates | R-299 | 25 | 3 | Drugs (6) |
CMF-01966 | PCDH9 | down-regulates | ZFX | activates | R-798 | 23 | 1 | Drugs (1) |
CMF-02007 | PCDH9 | down-regulates | PLAG1 | activates | R-2510 | 5 | 1 | Drugs (5) |
CMF-02778 | DHX30 | up-regulates | NFKB1 | activates | R-299 | 25 | 3 | Drugs (6) |
CMF-03048 | OR5D14 | up-regulates | RUNX1 | activates | R-283 | 15 | 3 | Drugs (5) |
CMF-03267 | HRNR | down-regulates | ZFX | activates | R-798 | 23 | 5 | Drugs (1) |
CMF-03288 | HRNR | down-regulates | PLAG1 | activates | R-2510 | 5 | 1 | Drugs (5) |
CMF-03695 | DSP | up-regulates | NFKB1 | activates | R-299 | 25 | 13 | Drugs (6) |
CMF-03925 | DSP | up-regulates | CEBPA | activates | R-2596 | 21 | 13 | Drugs (6) |
CMF-04510 | LAMC3 | down-regulates | NFKB1 | activates | R-299 | 25 | 7 | Drugs (6) |
CMF-04673 | RUSC2 | down-regulates | ELF1 | activates | R-334 | 24 | 4 | Drugs (6) |
CMF-04943 | ABCC5 | down-regulates | FOXJ3 | activates | R-1168 | 23 | 7 | Drugs (7) |
CMF-05048 | ITPR3 | up-regulates | ELF1 | activates | R-334 | 24 | 2 | Drugs (6) |
CMF-05079 | SPEG | down-regulates | JUN | activates | R-215 | 25 | 7 | Drugs (7) |
CMF-05792 | ADAMTS19 | down-regulates | PLAG1 | activates | R-2510 | 5 | 3 | Drugs (5) |
CMF-05888 | FAM71B | down-regulates | JUN | activates | R-215 | 25 | 1 | Drugs (7) |
CMF-06315 | AFF2 | down-regulates | PLAG1 | activates | R-2510 | 5 | 1 | Drugs (5) |
CMF-06549 | SETD2 | down-regulates | PLAG1 | activates | R-2510 | 5 | 1 | Drugs (5) |
CMF-06906 | ATRX | down-regulates | FOXC1 | activates | R-646 | 20 | 14 | Drugs (15) Regulator Drugs (0)Regulon Drugs (15)ALEPLASININ, SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, OCRIPLASMIN, TOSEDOSTAT, BHQ-880, VESENCUMAB, ABITUZUMAB |
CMF-06930 | ATRX | down-regulates | RUNX1 | activates | R-283 | 15 | 8 | Drugs (5) |
CMF-07248 | NOD2 | up-regulates | ELF1 | activates | R-334 | 24 | 4 | Drugs (6) |
CMF-08250 | KIF4A | down-regulates | NFKB1 | activates | R-299 | 25 | 8 | Drugs (6) |
CMF-08584 | FOXR2 | down-regulates | NFKB1 | activates | R-299 | 25 | 3 | Drugs (6) |
CMF-08599 | FOXR2 | down-regulates | RUNX1 | activates | R-283 | 15 | 2 | Drugs (5) |
CMF-09025 | NALCN | down-regulates | JUN | activates | R-215 | 25 | 7 | Drugs (7) |
CMF-09291 | RP1 | down-regulates | PLAG1 | activates | R-2510 | 5 | 3 | Drugs (5) |
CMF-09342 | SPTA1 | down-regulates | RUNX1 | activates | R-283 | 15 | 1 | Drugs (5) |
CMF-09345 | SPTA1 | down-regulates | FOXJ3 | activates | R-1168 | 23 | 2 | Drugs (7) |
CMF-10075 | ATP8A2 | down-regulates | CEBPA | activates | R-2596 | 21 | 7 | Drugs (6) |
CMF-12179 | CELSR1 | up-regulates | ELF1 | activates | R-334 | 24 | 1 | Drugs (6) |
CMF-12214 | GPR98 | down-regulates | NFKB1 | activates | R-299 | 25 | 6 | Drugs (6) |
CMF-12248 | GPR98 | down-regulates | ELF1 | activates | R-334 | 24 | 3 | Drugs (6) |
CMF-12305 | GPR98 | down-regulates | ZFX | activates | R-798 | 23 | 8 | Drugs (1) |
CMF-12378 | GPR98 | down-regulates | PLAG1 | activates | R-2510 | 5 | 3 | Drugs (5) |
CMF-13374 | FMN1 | up-regulates | NFKB1 | activates | R-299 | 25 | 7 | Drugs (6) |
CMF-13480 | FMN1 | up-regulates | FOXJ3 | activates | R-1168 | 23 | 13 | Drugs (7) |
CMF-13834 | ADAMTS8 | down-regulates | CEBPA | activates | R-2596 | 21 | 6 | Drugs (6) |
CMF-14113 | HEATR7B2 | down-regulates | FOXC1 | activates | R-646 | 20 | 2 | Drugs (15) Regulator Drugs (0)Regulon Drugs (15)ALEPLASININ, SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, OCRIPLASMIN, TOSEDOSTAT, BHQ-880, VESENCUMAB, ABITUZUMAB |
CMF-14127 | CD1D | up-regulates | NFKB1 | activates | R-299 | 25 | 2 | Drugs (6) |
CMF-14370 | ST18 | down-regulates | NFKB1 | activates | R-299 | 25 | 2 | Drugs (6) |
CMF-14377 | ST18 | down-regulates | PLAG1 | activates | R-2510 | 5 | 1 | Drugs (5) |
CMF-15250 | HCN1 | up-regulates | NFKB1 | activates | R-299 | 25 | 2 | Drugs (6) |
CMF-15613 | DCHS2 | up-regulates | NFKB1 | activates | R-299 | 25 | 8 | Drugs (6) |
CMF-15664 | DCHS2 | up-regulates | FOXJ3 | activates | R-1168 | 23 | 4 | Drugs (7) |
CMF-15924 | OR13C8 | down-regulates | NFKB1 | activates | R-299 | 25 | 4 | Drugs (6) |
CMF-16222 | USP11 | down-regulates | FOXC1 | activates | R-646 | 20 | 9 | Drugs (15) Regulator Drugs (0)Regulon Drugs (15)ALEPLASININ, SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, OCRIPLASMIN, TOSEDOSTAT, BHQ-880, VESENCUMAB, ABITUZUMAB |
CMF-16394 | SUSD5 | up-regulates | ELF1 | activates | R-334 | 24 | 3 | Drugs (6) |
CMF-17130 | CDH18 | up-regulates | NFKB1 | activates | R-299 | 25 | 3 | Drugs (6) |
CMF-17431 | LGALS8 | up-regulates | CEBPG | activates | R-1041 | 23 | 2 | Drugs (7) |
CMF-17617 | ODZ1 | down-regulates | FOXJ3 | activates | R-1168 | 23 | 2 | Drugs (7) |
CMF-18115 | KCNH5 | down-regulates | PLAG1 | activates | R-2510 | 5 | 1 | Drugs (5) |
CMF-19225 | NF1 | up-regulates | NFKB1 | activates | R-299 | 25 | 14 | Drugs (6) |
CMF-19265 | NF1 | up-regulates | ELF1 | activates | R-334 | 24 | 10 | Drugs (6) |
CMF-19361 | NF1 | up-regulates | JUN | activates | R-215 | 25 | 16 | Drugs (7) |
CMF-19376 | NF1 | up-regulates | FOXC1 | activates | R-646 | 20 | 13 | Drugs (15) Regulator Drugs (0)Regulon Drugs (15)ALEPLASININ, SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, OCRIPLASMIN, TOSEDOSTAT, BHQ-880, VESENCUMAB, ABITUZUMAB |
CMF-19408 | NF1 | up-regulates | RUNX1 | activates | R-283 | 15 | 9 | Drugs (5) |
CMF-19599 | NF1 | up-regulates | PLAG1 | activates | R-2510 | 5 | 4 | Drugs (5) |
CMF-20370 | CUX2 | up-regulates | NFKB1 | activates | R-299 | 25 | 7 | Drugs (6) |
CMF-20385 | CUX2 | up-regulates | ELF1 | activates | R-334 | 24 | 4 | Drugs (6) |
CMF-20422 | CUX2 | up-regulates | FOXC1 | activates | R-646 | 20 | 6 | Drugs (15) Regulator Drugs (0)Regulon Drugs (15)ALEPLASININ, SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, OCRIPLASMIN, TOSEDOSTAT, BHQ-880, VESENCUMAB, ABITUZUMAB |
CMF-20663 | CYP4B1 | up-regulates | ELF1 | activates | R-334 | 24 | 2 | Drugs (6) |
CMF-20936 | KLHL13 | up-regulates | NFKB1 | activates | R-299 | 25 | 2 | Drugs (6) |
CMF-20945 | KLHL13 | up-regulates | ELF1 | activates | R-334 | 24 | 3 | Drugs (6) |
CMF-21001 | KRTAP4-7 | up-regulates | NFKB1 | activates | R-299 | 25 | 11 | Drugs (6) |
CMF-21602 | MUC17 | up-regulates | ELF1 | activates | R-334 | 24 | 8 | Drugs (6) |
CMF-21662 | MUC17 | up-regulates | RUNX1 | activates | R-283 | 15 | 8 | Drugs (5) |
CMF-21883 | PRAME | up-regulates | ELF1 | activates | R-334 | 24 | 5 | Drugs (6) |
CMF-22147 | PDGFRA | down-regulates | FOXC1 | activates | R-646 | 20 | 2 | Drugs (15) Regulator Drugs (0)Regulon Drugs (15)ALEPLASININ, SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, OCRIPLASMIN, TOSEDOSTAT, BHQ-880, VESENCUMAB, ABITUZUMAB |
CMF-22594 | IDH1 | down-regulates | RUNX1 | activates | R-283 | 15 | 7 | Drugs (5) |
CMF-23330 | CCDC132 | up-regulates | NFKB1 | activates | R-299 | 25 | 4 | Drugs (6) |
CMF-23340 | CCDC132 | up-regulates | CEBPG | activates | R-1041 | 23 | 2 | Drugs (7) |
CMF-24379 | PREX1 | up-regulates | ELF1 | activates | R-334 | 24 | 4 | Drugs (6) |
CMF-26298 | CHGB | up-regulates | NFKB1 | activates | R-299 | 25 | 4 | Drugs (6) |
CMF-26307 | CHGB | up-regulates | ELF1 | activates | R-334 | 24 | 3 | Drugs (6) |
CMF-28205 | REPIN1 | up-regulates | NFKB1 | activates | R-299 | 25 | 4 | Drugs (6) |
CMF-28219 | REPIN1 | up-regulates | FOXJ3 | activates | R-1168 | 23 | 3 | Drugs (7) |
CMF-28413 | MYO9B | down-regulates | RUNX1 | activates | R-283 | 15 | 7 | Drugs (5) |
CMF-28457 | MYO9B | down-regulates | PLAG1 | activates | R-2510 | 5 | 4 | Drugs (5) |
CMF-28676 | PCNX | down-regulates | PLAG1 | activates | R-2510 | 5 | 1 | Drugs (5) |
CMF-29161 | AQP10 | down-regulates | NFKB1 | activates | R-299 | 25 | 10 | Drugs (6) |
CMF-29578 | ESRRB | down-regulates | NFKB1 | activates | R-299 | 25 | 9 | Drugs (6) |
CMF-29846 | ABCC9 | up-regulates | NFKB1 | activates | R-299 | 25 | 6 | Drugs (6) |
CMF-29871 | ABCC9 | up-regulates | JUN | activates | R-215 | 25 | 8 | Drugs (7) |
CMF-30177 | OR4K13 | down-regulates | NFKB1 | activates | R-299 | 25 | 5 | Drugs (6) |
CMF-30634 | SALL4 | down-regulates | RUNX1 | activates | R-283 | 15 | 5 | Drugs (5) |
CMF-30754 | POLRMT | up-regulates | RUNX1 | activates | R-283 | 15 | 4 | Drugs (5) |
CMF-31047 | PNPLA7 | up-regulates | ELF1 | activates | R-334 | 24 | 2 | Drugs (6) |
CMF-33878 | ZNF292 | up-regulates | hsa-mir-125b | represses | R-646 | 10 | 8 | Drugs (15) Regulator Drugs (0)Regulon Drugs (15)ALEPLASININ, SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, OCRIPLASMIN, TOSEDOSTAT, BHQ-880, VESENCUMAB, ABITUZUMAB |
CMF-33964 | MCM6 | down-regulates | hsa-mir-139 | represses | R-646 | 58 | 34 | Drugs (15) Regulator Drugs (0)Regulon Drugs (15)ALEPLASININ, SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, OCRIPLASMIN, TOSEDOSTAT, BHQ-880, VESENCUMAB, ABITUZUMAB |
CMF-34014 | MCM6 | down-regulates | hsa-mir-129 | represses | R-646 | 155 | 76 | Drugs (15) Regulator Drugs (0)Regulon Drugs (15)ALEPLASININ, SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, OCRIPLASMIN, TOSEDOSTAT, BHQ-880, VESENCUMAB, ABITUZUMAB |
CMF-34213 | UBE3C | up-regulates | hsa-mir-551b | represses | R-646 | 22 | 2 | Drugs (15) Regulator Drugs (0)Regulon Drugs (15)ALEPLASININ, SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, OCRIPLASMIN, TOSEDOSTAT, BHQ-880, VESENCUMAB, ABITUZUMAB |
CMF-34416 | GCC2 | up-regulates | hsa-mir-153 | represses | R-646 | 62 | 3 | Drugs (15) Regulator Drugs (0)Regulon Drugs (15)ALEPLASININ, SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, OCRIPLASMIN, TOSEDOSTAT, BHQ-880, VESENCUMAB, ABITUZUMAB |
CMF-34736 | ABCC5 | up-regulates | hsa-mir-139 | represses | R-646 | 58 | 26 | Drugs (15) Regulator Drugs (0)Regulon Drugs (15)ALEPLASININ, SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, OCRIPLASMIN, TOSEDOSTAT, BHQ-880, VESENCUMAB, ABITUZUMAB |
CMF-34820 | NUP210L | up-regulates | hsa-mir-9 | represses | R-646 | 25 | 20 | Drugs (15) Regulator Drugs (0)Regulon Drugs (15)ALEPLASININ, SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, OCRIPLASMIN, TOSEDOSTAT, BHQ-880, VESENCUMAB, ABITUZUMAB |
CMF-34829 | NUP210L | up-regulates | hsa-mir-9 | represses | R-1168 | 25 | 20 | Drugs (7) |
CMF-34964 | ADAMTS19 | up-regulates | hsa-mir-9 | represses | R-1168 | 25 | 2 | Drugs (7) |
CMF-35161 | AFF2 | up-regulates | hsa-mir-9 | represses | R-1168 | 25 | 3 | Drugs (7) |
CMF-35225 | ATRX | up-regulates | hsa-mir-139 | represses | R-646 | 58 | 58 | Drugs (15) Regulator Drugs (0)Regulon Drugs (15)ALEPLASININ, SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, OCRIPLASMIN, TOSEDOSTAT, BHQ-880, VESENCUMAB, ABITUZUMAB |
CMF-35324 | ATRX | up-regulates | hsa-mir-551b | represses | R-646 | 22 | 17 | Drugs (15) Regulator Drugs (0)Regulon Drugs (15)ALEPLASININ, SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, OCRIPLASMIN, TOSEDOSTAT, BHQ-880, VESENCUMAB, ABITUZUMAB |
CMF-35359 | ATRX | up-regulates | hsa-mir-98 | represses | R-646 | 8 | 8 | Drugs (15) Regulator Drugs (0)Regulon Drugs (15)ALEPLASININ, SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, OCRIPLASMIN, TOSEDOSTAT, BHQ-880, VESENCUMAB, ABITUZUMAB |
CMF-35380 | ATRX | up-regulates | hsa-mir-301 | represses | R-646 | 37 | 32 | Drugs (15) Regulator Drugs (0)Regulon Drugs (15)ALEPLASININ, SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, OCRIPLASMIN, TOSEDOSTAT, BHQ-880, VESENCUMAB, ABITUZUMAB |
CMF-35573 | ATRX | up-regulates | hsa-mir-9 | represses | R-646 | 25 | 25 | Drugs (15) Regulator Drugs (0)Regulon Drugs (15)ALEPLASININ, SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, OCRIPLASMIN, TOSEDOSTAT, BHQ-880, VESENCUMAB, ABITUZUMAB |
CMF-35584 | ATRX | up-regulates | hsa-mir-9 | represses | R-1168 | 25 | 25 | Drugs (7) |
CMF-35775 | NOD2 | down-regulates | hsa-mir-153 | represses | R-646 | 62 | 32 | Drugs (15) Regulator Drugs (0)Regulon Drugs (15)ALEPLASININ, SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, OCRIPLASMIN, TOSEDOSTAT, BHQ-880, VESENCUMAB, ABITUZUMAB |
CMF-36131 | TNK2 | up-regulates | hsa-mir-125b | represses | R-646 | 10 | 7 | Drugs (15) Regulator Drugs (0)Regulon Drugs (15)ALEPLASININ, SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, OCRIPLASMIN, TOSEDOSTAT, BHQ-880, VESENCUMAB, ABITUZUMAB |
CMF-36223 | ABCC4 | down-regulates | hsa-mir-153 | represses | R-646 | 62 | 1 | Drugs (15) Regulator Drugs (0)Regulon Drugs (15)ALEPLASININ, SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, OCRIPLASMIN, TOSEDOSTAT, BHQ-880, VESENCUMAB, ABITUZUMAB |
CMF-36314 | FOXR2 | up-regulates | hsa-mir-301 | represses | R-646 | 37 | 12 | Drugs (15) Regulator Drugs (0)Regulon Drugs (15)ALEPLASININ, SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, OCRIPLASMIN, TOSEDOSTAT, BHQ-880, VESENCUMAB, ABITUZUMAB |
CMF-36840 | SEMG1 | up-regulates | hsa-mir-125b | represses | R-646 | 10 | 2 | Drugs (15) Regulator Drugs (0)Regulon Drugs (15)ALEPLASININ, SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, OCRIPLASMIN, TOSEDOSTAT, BHQ-880, VESENCUMAB, ABITUZUMAB |
CMF-36844 | SEMG1 | up-regulates | hsa-mir-9 | represses | R-646 | 25 | 5 | Drugs (15) Regulator Drugs (0)Regulon Drugs (15)ALEPLASININ, SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, OCRIPLASMIN, TOSEDOSTAT, BHQ-880, VESENCUMAB, ABITUZUMAB |
CMF-37436 | HTR3E | up-regulates | hsa-mir-125b | represses | R-646 | 10 | 1 | Drugs (15) Regulator Drugs (0)Regulon Drugs (15)ALEPLASININ, SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, OCRIPLASMIN, TOSEDOSTAT, BHQ-880, VESENCUMAB, ABITUZUMAB |
CMF-37458 | HTR3E | up-regulates | hsa-mir-129 | represses | R-646 | 155 | 71 | Drugs (15) Regulator Drugs (0)Regulon Drugs (15)ALEPLASININ, SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, OCRIPLASMIN, TOSEDOSTAT, BHQ-880, VESENCUMAB, ABITUZUMAB |
CMF-37651 | NRXN1 | down-regulates | hsa-mir-551b | represses | R-646 | 22 | 3 | Drugs (15) Regulator Drugs (0)Regulon Drugs (15)ALEPLASININ, SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, OCRIPLASMIN, TOSEDOSTAT, BHQ-880, VESENCUMAB, ABITUZUMAB |
CMF-38004 | XK | up-regulates | hsa-mir-9 | represses | R-1168 | 25 | 3 | Drugs (7) |
CMF-38640 | OR5I1 | up-regulates | hsa-mir-9 | represses | R-1168 | 25 | 20 | Drugs (7) |
CMF-38681 | TIE1 | down-regulates | hsa-mir-129 | represses | R-646 | 155 | 58 | Drugs (15) Regulator Drugs (0)Regulon Drugs (15)ALEPLASININ, SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, OCRIPLASMIN, TOSEDOSTAT, BHQ-880, VESENCUMAB, ABITUZUMAB |
CMF-38965 | PRPF40B | up-regulates | hsa-mir-125b | represses | R-646 | 10 | 10 | Drugs (15) Regulator Drugs (0)Regulon Drugs (15)ALEPLASININ, SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, OCRIPLASMIN, TOSEDOSTAT, BHQ-880, VESENCUMAB, ABITUZUMAB |
CMF-39493 | NF1 | down-regulates | hsa-mir-551b | represses | R-646 | 22 | 18 | Drugs (15) Regulator Drugs (0)Regulon Drugs (15)ALEPLASININ, SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, OCRIPLASMIN, TOSEDOSTAT, BHQ-880, VESENCUMAB, ABITUZUMAB |
CMF-39508 | NF1 | down-regulates | hsa-mir-153 | represses | R-646 | 62 | 28 | Drugs (15) Regulator Drugs (0)Regulon Drugs (15)ALEPLASININ, SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, OCRIPLASMIN, TOSEDOSTAT, BHQ-880, VESENCUMAB, ABITUZUMAB |
CMF-39548 | NF1 | down-regulates | hsa-mir-125b | represses | R-646 | 10 | 9 | Drugs (15) Regulator Drugs (0)Regulon Drugs (15)ALEPLASININ, SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, OCRIPLASMIN, TOSEDOSTAT, BHQ-880, VESENCUMAB, ABITUZUMAB |
CMF-39654 | NF1 | down-regulates | hsa-mir-9 | represses | R-646 | 25 | 10 | Drugs (15) Regulator Drugs (0)Regulon Drugs (15)ALEPLASININ, SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, OCRIPLASMIN, TOSEDOSTAT, BHQ-880, VESENCUMAB, ABITUZUMAB |
CMF-39659 | NF1 | down-regulates | hsa-mir-9 | represses | R-1168 | 25 | 10 | Drugs (7) |
CMF-39747 | RPSAP58 | down-regulates | hsa-mir-301 | represses | R-646 | 37 | 12 | Drugs (15) Regulator Drugs (0)Regulon Drugs (15)ALEPLASININ, SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, OCRIPLASMIN, TOSEDOSTAT, BHQ-880, VESENCUMAB, ABITUZUMAB |
CMF-40051 | CUX2 | down-regulates | hsa-mir-153 | represses | R-646 | 62 | 10 | Drugs (15) Regulator Drugs (0)Regulon Drugs (15)ALEPLASININ, SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, OCRIPLASMIN, TOSEDOSTAT, BHQ-880, VESENCUMAB, ABITUZUMAB |
CMF-40321 | MUC17 | down-regulates | hsa-mir-125b | represses | R-646 | 10 | 9 | Drugs (15) Regulator Drugs (0)Regulon Drugs (15)ALEPLASININ, SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, OCRIPLASMIN, TOSEDOSTAT, BHQ-880, VESENCUMAB, ABITUZUMAB |
CMF-40416 | PDGFRA | up-regulates | hsa-mir-9 | represses | R-646 | 25 | 7 | Drugs (15) Regulator Drugs (0)Regulon Drugs (15)ALEPLASININ, SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, OCRIPLASMIN, TOSEDOSTAT, BHQ-880, VESENCUMAB, ABITUZUMAB |
CMF-40420 | PDGFRA | up-regulates | hsa-mir-9 | represses | R-1168 | 25 | 7 | Drugs (7) |
CMF-40469 | IDH1 | up-regulates | hsa-mir-139 | represses | R-646 | 58 | 58 | Drugs (15) Regulator Drugs (0)Regulon Drugs (15)ALEPLASININ, SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, OCRIPLASMIN, TOSEDOSTAT, BHQ-880, VESENCUMAB, ABITUZUMAB |
CMF-40570 | IDH1 | up-regulates | hsa-mir-551b | represses | R-646 | 22 | 17 | Drugs (15) Regulator Drugs (0)Regulon Drugs (15)ALEPLASININ, SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, OCRIPLASMIN, TOSEDOSTAT, BHQ-880, VESENCUMAB, ABITUZUMAB |
CMF-40606 | IDH1 | up-regulates | hsa-mir-153 | represses | R-646 | 62 | 62 | Drugs (15) Regulator Drugs (0)Regulon Drugs (15)ALEPLASININ, SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, OCRIPLASMIN, TOSEDOSTAT, BHQ-880, VESENCUMAB, ABITUZUMAB |
CMF-40681 | IDH1 | up-regulates | hsa-mir-98 | represses | R-646 | 8 | 8 | Drugs (15) Regulator Drugs (0)Regulon Drugs (15)ALEPLASININ, SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, OCRIPLASMIN, TOSEDOSTAT, BHQ-880, VESENCUMAB, ABITUZUMAB |
CMF-40702 | IDH1 | up-regulates | hsa-mir-301 | represses | R-646 | 37 | 32 | Drugs (15) Regulator Drugs (0)Regulon Drugs (15)ALEPLASININ, SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, OCRIPLASMIN, TOSEDOSTAT, BHQ-880, VESENCUMAB, ABITUZUMAB |
CMF-40863 | IDH1 | up-regulates | hsa-mir-9 | represses | R-646 | 25 | 25 | Drugs (15) Regulator Drugs (0)Regulon Drugs (15)ALEPLASININ, SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, OCRIPLASMIN, TOSEDOSTAT, BHQ-880, VESENCUMAB, ABITUZUMAB |
CMF-40874 | IDH1 | up-regulates | hsa-mir-9 | represses | R-1168 | 25 | 25 | Drugs (7) |
CMF-41883 | IQSEC3 | up-regulates | hsa-mir-9 | represses | R-1168 | 25 | 17 | Drugs (7) |
CMF-42127 | MAGEB1 | up-regulates | hsa-mir-98 | represses | R-646 | 8 | 2 | Drugs (15) Regulator Drugs (0)Regulon Drugs (15)ALEPLASININ, SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, OCRIPLASMIN, TOSEDOSTAT, BHQ-880, VESENCUMAB, ABITUZUMAB |
CMF-42139 | AADACL4 | up-regulates | hsa-mir-9 | represses | R-1168 | 25 | 3 | Drugs (7) |
CMF-42406 | CXorf57 | up-regulates | hsa-mir-9 | represses | R-1168 | 25 | 4 | Drugs (7) |
CMF-42448 | ANKRD36 | down-regulates | hsa-mir-9 | represses | R-646 | 25 | 11 | Drugs (15) Regulator Drugs (0)Regulon Drugs (15)ALEPLASININ, SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, OCRIPLASMIN, TOSEDOSTAT, BHQ-880, VESENCUMAB, ABITUZUMAB |
CMF-42640 | MYO9B | up-regulates | hsa-mir-129 | represses | R-646 | 155 | 15 | Drugs (15) Regulator Drugs (0)Regulon Drugs (15)ALEPLASININ, SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, OCRIPLASMIN, TOSEDOSTAT, BHQ-880, VESENCUMAB, ABITUZUMAB |
CMF-42689 | IFT172 | up-regulates | hsa-mir-301 | represses | R-646 | 37 | 7 | Drugs (15) Regulator Drugs (0)Regulon Drugs (15)ALEPLASININ, SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, OCRIPLASMIN, TOSEDOSTAT, BHQ-880, VESENCUMAB, ABITUZUMAB |
CMF-42760 | AQP10 | up-regulates | hsa-mir-129 | represses | R-646 | 155 | 41 | Drugs (15) Regulator Drugs (0)Regulon Drugs (15)ALEPLASININ, SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, OCRIPLASMIN, TOSEDOSTAT, BHQ-880, VESENCUMAB, ABITUZUMAB |
CMF-42787 | AQP10 | up-regulates | hsa-mir-301 | represses | R-646 | 37 | 10 | Drugs (15) Regulator Drugs (0)Regulon Drugs (15)ALEPLASININ, SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, OCRIPLASMIN, TOSEDOSTAT, BHQ-880, VESENCUMAB, ABITUZUMAB |
CMF-43075 | ABCC9 | down-regulates | hsa-mir-153 | represses | R-646 | 62 | 21 | Drugs (15) Regulator Drugs (0)Regulon Drugs (15)ALEPLASININ, SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, OCRIPLASMIN, TOSEDOSTAT, BHQ-880, VESENCUMAB, ABITUZUMAB |
CMF-43261 | SALL4 | up-regulates | hsa-mir-125b | represses | R-646 | 10 | 6 | Drugs (15) Regulator Drugs (0)Regulon Drugs (15)ALEPLASININ, SULTHIAME, CILENGITIDE, SENICAPOC, DKN-01, CG250 177LU, GIRENTUXIMAB, CG250 111IN, INTETUMUMAB, COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, OCRIPLASMIN, TOSEDOSTAT, BHQ-880, VESENCUMAB, ABITUZUMAB |
CMF-31522 | EGF_RECEPTOR_SIGNALING_PATHWAY | up-regulates | ELF1 | activates | R-334 | 24 | 5 | Drugs (6) |
CMF-31572 | EGF_RECEPTOR_SIGNALING_PATHWAY | up-regulates | CEBPA | activates | R-2596 | 21 | 6 | Drugs (6) |
CMF-31765 | ERBB4_SIGNALING_EVENTS | up-regulates | NFKB1 | activates | R-299 | 25 | 2 | Drugs (6) |
CMF-31789 | ERBB4_SIGNALING_EVENTS | up-regulates | ZFX | activates | R-798 | 23 | 6 | Drugs (1) |
CMF-32124 | A6B1_AND_A6B4_INTEGRIN_SIGNALING | up-regulates | CEBPA | activates | R-2596 | 21 | 7 | Drugs (6) |
CMF-32602 | IL23_MEDIATED_SIGNALING_EVENTS | up-regulates | CEBPA | activates | R-2596 | 21 | 2 | Drugs (6) |
CMF-32827 | E_CADHERIN_SIGNALING_IN_KERATINOCYTES | up-regulates | CEBPA | activates | R-2596 | 21 | 5 | Drugs (6) |
CMF-32868 | EPHA2_FORWARD_SIGNALING | up-regulates | NFKB1 | activates | R-299 | 25 | 1 | Drugs (6) |
CMF-32876 | EPHA2_FORWARD_SIGNALING | up-regulates | ELF1 | activates | R-334 | 24 | 5 | Drugs (6) |
CMF-33218 | EPHRIN_B_REVERSE_SIGNALING | up-regulates | NFKB1 | activates | R-299 | 25 | 4 | Drugs (6) |
CMF-33250 | EPHRIN_B_REVERSE_SIGNALING | up-regulates | CEBPA | activates | R-2596 | 21 | 4 | Drugs (6) |
CMF-33317 | ERBB1_DOWNSTREAM_SIGNALING | up-regulates | ELF1 | activates | R-334 | 24 | 4 | Drugs (6) |
CMF-33364 | ERBB1_DOWNSTREAM_SIGNALING | up-regulates | CEBPA | activates | R-2596 | 21 | 6 | Drugs (6) |